Related Experiment Video
Updated: Jul 8, 2026
Making Gynogenetic Diploid Zebrafish by Early Pressure
Published on: June 30, 2009
GW-9662, a peroxisome proliferator-activated receptor γ (PPARγ) inhibitor, impairs early embryonic development in
Sunil Sharma1, Kanchaka Senarath Pathirajage1, Tyler Johnson1
1Department of Biological Sciences, Clemson University, Clemson, SC, USA.
Abstract:
Peroxisome proliferator-activated receptor γ (PPARγ) functions as a nuclear transcription factor with primary roles in lipid and glucose metabolism and adipocyte differentiation. Despite intensive research in metabolic contexts, its role during early vertebrate development remains underexplored. Our study focused on understanding PPARγ's developmental role by using a PPARγ antagonist, GW-9662 (GW), in zebrafish embryos. We exposed embryos to GW from 6 hours post-fertilization (hpf) to 24 hpf and observed that the embryos were ventralized by 24 hpf. Western Blot and immunohistochemistry for PPARγ protein demonstrated that GW-mediated PPARγ inhibition may be localized within the embryos. Transcriptomic analysis revealed that exposure to GW led to dysregulation of multiple biological pathways, including cytoskeletal organization, lipid biosynthesis, and epithelial-to-mesenchymal transition (EMT). Immunohistochemistry further validated these findings, demonstrating increased lipid accumulation, cytoskeletal disruption, and altered EMT markers. Our findings suggest that while GW plays a crucial role in multiple physiological processes during early embryogenesis, further research is needed to examine if these impacts are mediated by PPARγ.
Insights
Peroxisome proliferator-activated receptor γ (PPARγ) inhibition in zebrafish embryos caused ventralization and disrupted lipid metabolism and cell structure. These findings highlight PPARγ
Area of Science:
- Developmental Biology
- Molecular Endocrinology
Background:
- Peroxisome proliferator-activated receptor γ (PPARγ) is a nuclear transcription factor crucial for lipid and glucose metabolism and adipocyte differentiation.
- Its role in early vertebrate development is largely unexplored, despite extensive research in metabolic contexts.
Purpose of the Study:
- To investigate the developmental role of PPARγ during early embryogenesis.
- To analyze the effects of PPARγ inhibition using a specific antagonist in zebrafish embryos.
Main Methods:
- Zebrafish embryos were exposed to the PPARγ antagonist GW-9662 (GW) from 6 to 24 hours post-fertilization.
- Western Blot and immunohistochemistry were used to assess PPARγ protein levels and localization.
- Transcriptomic analysis identified dysregulated biological pathways.
- Immunohistochemistry validated changes in lipid accumulation, cytoskeletal organization, and epithelial-to-mesenchymal transition (EMT) markers.
Main Results:
- Exposure to GW resulted in ventralized zebrafish embryos by 24 hours post-fertilization.
- GW-mediated PPARγ inhibition was observed to be localized within the embryos.
- Transcriptomic analysis revealed dysregulation in pathways including cytoskeletal organization, lipid biosynthesis, and EMT.
- Validation confirmed increased lipid accumulation, cytoskeletal disruption, and altered EMT markers.
Conclusions:
- PPARγ inhibition during early zebrafish embryogenesis leads to significant developmental abnormalities, including ventralization.
- The study identified disruptions in lipid metabolism, cytoskeletal organization, and EMT pathways.
- While GW-9662 impacts key developmental processes, further research is required to definitively attribute these effects to PPARγ mediation.
